Holy Grail' of Oral Insulin Gives Way to Other Tablets at Novo


More than 30 years after diabetics began injecting themselves with the modern form of insulin, treatments in a pill seem as elusive as ever. Delivery of the hormone in a tablet is still considered the "holy grail," according to Mads Krogsgaard Thomsen, the chief science officer of Novo Nordisk A/S.



from Biotech News